Abstracts tagged "patient and rheumatoid arthritis (RA)"

Abstract Number: 1239 • 2017 ACR/ARHP Annual Meeting
Web Based Educational Intervention to Improve Cardiovascular Disease Knowledge Among RA Patients
Meenakshi Jolly¹, Aman Kugasia², Carlos Cordova³, Joshlean Fair³, Eleftheria Steinig⁴, Rasa Kazkauskaite⁵, Lisa Walt⁶, Mondira Sengupta⁷ and Joel A. Block², ¹Rush, Chicago, IL, ²Division of Rheumatology, Rush University Medical Center, Chicago, IL, ³Rheumatology, Rush University Medical Center, Chicago, IL, ⁴Northwestern Univeristy, Chicago, IL, ⁵Rush University, chicago, IL, ⁶American Hospital Association, Chicago, IL, ⁷John H Stroger Hospital of Cook County, Chicago, IL
Background/Purpose: The major cause of mortality in patients with Rheumatoid Arthritis (RA) is cardiovascular disease (CVD). However traditionally, very few RA patients receive screening and…
Abstract Number: 2246 • 2017 ACR/ARHP Annual Meeting
Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis
Lisa Zickuhr¹, William Messner², Abby Abelson³ and M. Elaine Husni⁴, ¹Rheumatology, Cleveland Clinic Foundation, Cleveland, OH, ²Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ³Department of Rheumatologic & Immunologic Disease, Cleveland Clinic Foundation, Cleveland, OH, ⁴Cleveland Clinic, Cleveland, OH
Background/Purpose: Rheumatoid arthritis (RA) raises cardiovascular disease (CVD) risk, yet RA patients underestimate their personal risk. The principle of self-management posits patients will be…
Abstract Number: 2646 • 2015 ACR/ARHP Annual Meeting
Different Wording of the Patient Global Assessment Scale Leads to Different Rating of Disease Activity
Helga Radner¹, Paul Studenic², Stanley B. Cohen³, N Shadick⁴, C Iannaccone⁵, Elisabeth Lie⁶, Maria Dahl Mjaavatten⁶, Meredith Leigh Cohen³, Josef S. Smolen⁷ and Daniel Aletaha⁸, ¹Department of Internal Medicine III; Division of Rheumatology, Medical University of Vienna, Vienna, Austria, ²Department of Internal Medicine 3, Division of Rheumatology, Medical University Vienna, Vienna, Austria, ³Metroplex Clinical Research Center, Dallas, TX, ⁴Division of Rheumatology, Immunology & Allergy, Brigham and Women's Hosp, Boston, MA, ⁵Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, ⁶Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁷Dept of Medicine 3, Division of Rheumatology, Medical Univ Vienna, Vienna, Austria, ⁸Rheumatology, Medical University Vienna, Vienna, Austria
Background/Purpose: The patient global assessment of disease activity (PtGA) is a key variable in assessing RA disease activity and remission (REM). Typically assessed on a…
Abstract Number: 1022 • 2013 ACR/ARHP Annual Meeting
Initiation Of Biologic Therapy: The Patient Perspective
Amir Goren¹, Susan C. Bolge², Duncan Brown³, Roxanne Meyer⁴ and Seth Ginsberg⁵, ¹Kantar Health, New York, NY, ²Janssen Scientific Affairs, LLC, Horsham, PA, ³Kantar Health, New york, NY, ⁴Janssen Scientific Affairs, LLC, Horsham, NY, ⁵Creaky Joints, New York, NY
Background/Purpose: Current guidelines for the treatment of rheumatoid arthritis (RA) recommend that patients who are not adequately responding to treatment with disease modifying anti-rheumatic drugs…
Abstract Number: 985 • 2013 ACR/ARHP Annual Meeting
Efficacy Study Of Multimedia To Educate Rheumatoid Arthritis Patients
Julie A. Unk, Rheumatology, Washington Univ School of Med, St. Louis, MO
Abstract: Efficacy study of multimedia to educate rheumatoid arthritis patients Background/Purpose: The level of health literacy varies among rheumatoid arthritis (RA) patients in their ability…
Abstract Number: 467 • 2013 ACR/ARHP Annual Meeting
Adherence To Conventional Disease Modifying Anti-Rheumatic Drugs (cDMARDs) In Rheumatoid Arthritis (RA) Patients Treated In Association With a Biologic: A French Cross-Sectional Survey
Jean-Charles Balblanc¹, Philippe Dieude², Emilie Desfleurs³, Jeanne Antheaume³ and Chantal Deslandre⁴, ¹Rheumatology, Centre Hospitalier Général de Belfort, Belfort, France, ²Rheumatology, Rheumatology departement & INSERM U699, Paris Diderot university, APHP, Bichat hospital, Paris, France, ³Rheumatology, Roche SAS, Boulogne-Billancourt, France, ⁴Rheumatology, Cochin Hospital, Paris, France
Background/Purpose: A recent meta-analysis of aTNF and abatacept clinical trials established in those drugs that the efficacy of combination therapy with biologic is superior to…
Abstract Number: 2844 • 2013 ACR/ARHP Annual Meeting
The assessment of education requirements for patients with rheumatoidarthritis, based on the Polish version of the Educational Needs AssessmentTool (Pol-ENAT)
Matylda Sierakowska¹, Malgorzata Klepacka², Stanislaw Sierakowski³, Justyna Sierakowska⁴, Piotr Leszczynski⁵, Maria Majdan⁶, Marzena Olesinska⁷, Wojciech Romanowski⁸, Małgorzata Bykowska-Sochacka⁹, Slawomir Jeka¹⁰, Mwidimi Nondosi¹¹ and Elzbieta Krajewska-Kulak¹, ¹Department of Integrated Medical Care, Medical University of Bialystok, Bialystok, Poland, ²Department of Nephrology, Medical University of Bialystok, Bialystok, Poland, ³Department of Rheumatology and Internal Diseases, Medical University in Bialystok, Bialystok, Poland, ⁴Department of English Literature, University of Bialystok, Bialystok, Poland, ⁵Department of Rheumatology and Rehabilitation, Municipal Hospital in PoznaÅ„, Medical University in Poznan and J. Strus, Poznan, Poland, ⁶Department of Rheumatology and Connective Tissue Diseases, Medical University in Lublin, Lublin, Poland, ⁷Department of Connective Tissue Disease, Institute of Rheumatology, Warsaw, Poland, ⁸Poznań Centre of Rheumatology in Srem, Srem, Poland, ⁹9Dr. Jadwiga Titz-Kosko Regional Hospital for Rheumatic Diseases in Sopot, Sopot, Poland, ¹⁰Clinic of Rheumatology and Connective Tissue Diseases University Hospital No 2 in Bydgoszcz Collegium Medicum UMK in Torun, Bydgoszcz, Poland, ¹¹Academic & Clinical Unit for Musculoskeletal Nursing, University of Leeds, Leeds, United Kingdom
Background/Purpose: Chronic rheumatic diseases lead to large deficits in physical, mental and social functioning. Only an early diagnosis, followed by the implementation of comprehensive and…
Abstract Number: 1758 • 2013 ACR/ARHP Annual Meeting
Low Literacy Decision Aid Enhances Knowledge and Reduces Decisional Conflict Among Diverse Population Of Adults With Rheumatoid Arthritis: Results Of a Pilot Trial
Jennifer Barton¹, Laura Trupin², Gina Evans-Young³, John B. Imboden⁴, Dean Schillinger⁵, Victor M. Montori⁶ and Edward H. Yelin⁷, ¹Medicine, University of California, San Francisco, San Francisco, CA, ²Medicine, UC San Francisco, San Francisco, CA, ³Rheumatology, UCSF, San Francisco, CA, ⁴Department of Medicine, Division of Rheumatology, UCSF, San Francisco, CA, ⁵Medicine and Center for Vulnerable Populations, UCSF, San Francisco, CA, ⁶Divisions of Endocrinology and Diabetes and Health Care and Policy Research, Mayo Clinic, Rochester, MN, ⁷Arthritis Research Group, University of California, San Francisco, San Francisco, CA
Background/Purpose: Vulnerable populations with rheumatoid arthritis (RA) have poorer outcomes and report suboptimal shared decision-making communication. Patient involvement in the choice of disease modifying anti-rheumatic…
Abstract Number: 2108 • 2012 ACR/ARHP Annual Meeting
Identification of Four Parameters That Drive the Discordance Between the Patient and Physician Global Assessment in Rheumatoid Arthritis
William Bensen¹, Denis Choquette², Milton F. Baker³, Susan M. Otawa⁴ and Hayssam Khalil⁴, ¹St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, ²Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ³University of Victoria, Victoria, BC, Canada, ⁴Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada
Background/Purpose: Patient (PtGA) and physician (MDGA) global assessment of disease activity are standard outcome measures used to ascertain physician and patient subjective perception of disease…
Abstract Number: 1721 • 2012 ACR/ARHP Annual Meeting
Development of User-Focused Standards of Care for Rheumatoid Arthritis the Www.Eumusc.Net Project – Work Package 5
Michaela Stoffer¹, Josef S. Smolen², Anthony D. Woolf³, Tanja A. Stamm⁴ and EUMUSC.net working group WP 5⁵, ¹Internal Medicine III, division of rheumatology, Medical University of Vienna, Vienna, Austria, ²Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ³Rheumatology Dept, Royal Cornwall Hospital, Truro Cornwall, United Kingdom, ⁴Rheumatology, Medical University of Vienna, Vienna, Austria, ⁵Royal Cornwall Hospital Treliske, Truro Cornwall, United Kingdom
Background/Purpose: The EUMUSC.net project facilitates cooperation between EU Member States and promotes a comprehensive European strategy to optimise musculoskeletal health.The purpose of Work package 5,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].